Search details
1.
Perspectives on Adherence From the ACTG 5360 MINMON Trial: A Minimum Monitoring Approach With 12 Weeks of Sofosbuvir/Velpatasvir in Chronic Hepatitis C Treatment.
Clin Infect Dis
; 76(11): 1959-1968, 2023 06 08.
Article
in English
| MEDLINE | ID: mdl-36694361
2.
Estradiol and Spironolactone Plasma Pharmacokinetics Among Brazilian Transgender Women Using HIV Pre-Exposure Prophylaxis: Analysis of Potential Interactions.
Clin Pharmacokinet
; 62(7): 1031-1041, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37261664
3.
A case report of vaccine-induced immune thrombotic thrombocytopenia (VITT) with genetic analysis.
Front Cardiovasc Med
; 10: 1189320, 2023.
Article
in English
| MEDLINE | ID: mdl-37351283
4.
Characteristics of women diagnosed with mpox infection compared to men: A case series from Brazil.
Travel Med Infect Dis
; 56: 102663, 2023.
Article
in English
| MEDLINE | ID: mdl-37949306
5.
A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial.
Lancet Gastroenterol Hepatol
; 7(4): 307-317, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35026142
6.
Low PrEP adherence despite high retention among transgender women in Brazil: the PrEParadas study.
J Int AIDS Soc
; 25(3): e25896, 2022 03.
Article
in English
| MEDLINE | ID: mdl-35255199
7.
Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12â300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trial.
Lancet Infect Dis
; 21(6): 813-822, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33667406
8.
Clinical and Virologic Outcomes After Changes in First Antiretroviral Regimen at 7 Sites in the Caribbean, Central and South America Network.
J Acquir Immune Defic Syndr
; 71(1): 102-10, 2016 Jan 01.
Article
in English
| MEDLINE | ID: mdl-26761273
Results
1 -
8
de 8
1
Next >
>>